BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37699923)

  • 1. Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2).
    Towns C; Richer M; Jasaityte S; Stafford EJ; Joubert J; Antar T; Martinez-Carrasco A; Makarious MB; Casey B; Vitale D; Levine K; Leonard H; Pantazis CB; Screven LA; Hernandez DG; Wegel CE; Solle J; Nalls MA; Blauwendraat C; Singleton AB; Tan MMX; Iwaki H; Morris HR;
    NPJ Parkinsons Dis; 2023 Sep; 9(1):131. PubMed ID: 37699923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2).
    Lange LM; Avenali M; Ellis M; Illarionova A; Keller Sarmiento IJ; Tan AH; Madoev H; Galandra C; Junker J; Roopnarain K; Solle J; Wegel C; Fang ZH; Heutink P; Kumar KR; Lim SY; Valente EM; Nalls M; Blauwendraat C; Singleton A; Mencacci N; Lohmann K; Klein C;
    NPJ Parkinsons Dis; 2023 Jun; 9(1):100. PubMed ID: 37369645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding monogenic Parkinson's disease at a global scale.
    Junker J; Lange LM; Vollstedt EJ; Roopnarain K; Doquenia MLM; Annuar AA; Avenali M; Bardien S; Bahr N; Ellis M; Galandra C; Gasser T; Heutink P; Illarionova A; Kanana Y; Keller Sarmiento IJ; Kumar KR; Lim SY; Madoev H; Mata IF; Mencacci NE; Nalls MA; Padmanabhan S; Shambetova C; Solle J; Tan AH; Trinh J; Valente EM; Singleton A; Blauwendraat C; Lohmann K; Fang ZH; Klein C;
    medRxiv; 2024 Apr; ():. PubMed ID: 38529492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
    Vollstedt EJ; Madoev H; Aasly A; Ahmad-Annuar A; Al-Mubarak B; Alcalay RN; Alvarez V; Amorin I; Annesi G; Arkadir D; Bardien S; Barker RA; Barkhuizen M; Basak AN; Bonifati V; Boon A; Brighina L; Brockmann K; Carmine Belin A; Carr J; Clarimon J; Cornejo-Olivas M; Correia Guedes L; Corvol JC; Crosiers D; Damásio J; Das P; de Carvalho Aguiar P; De Rosa A; Dorszewska J; Ertan S; Ferese R; Ferreira J; Gatto E; Genç G; Giladi N; Gómez-Garre P; Hanagasi H; Hattori N; Hentati F; Hoffman-Zacharska D; Illarioshkin SN; Jankovic J; Jesús S; Kaasinen V; Kievit A; Klivenyi P; Kostic V; Koziorowski D; Kühn AA; Lang AE; Lim SY; Lin CH; Lohmann K; Markovic V; Martikainen MH; Mellick G; Merello M; Milanowski L; Mir P; Öztop-Çakmak Ö; Pimentel MMG; Pulkes T; Puschmann A; Rogaeva E; Sammler EM; Skaalum Petersen M; Skorvanek M; Spitz M; Suchowersky O; Tan AH; Termsarasab P; Thaler A; Tumas V; Valente EM; van de Warrenburg B; Williams-Gray CH; Wu RM; Zhang B; Zimprich A; Solle J; Padmanabhan S; Klein C
    PLoS One; 2023; 18(10):e0292180. PubMed ID: 37788254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Association Identifies Novel Etiological Insights Associated with Parkinson's Disease in African and African Admixed Populations.
    Rizig M; Bandres-Ciga S; Makarious MB; Ojo O; Crea PW; Abiodun O; Levine KS; Abubakar S; Achoru C; Vitale D; Adeniji O; Agabi O; Koretsky MJ; Agulanna U; Hall DA; Akinyemi R; Xie T; Ali M; Shamim EA; Ani-Osheku I; Padmanaban M; Arigbodi O; Standaert DG; Bello A; Dean M; Erameh C; Elsayed I; Farombi T; Okunoye O; Fawale M; Billingsley KJ; Imarhiagbe F; Jerez PA; Iwuozo E; Baker B; Komolafe M; Malik L; Nwani P; Daida K; Nwazor E; Miano-Burkhardt A; Nyandaiti Y; Fang ZH; Obiabo Y; Kluss JH; Odeniyi O; Hernandez D; Odiase F; Tayebi N; Ojini F; Sidranksy E; Onwuegbuzie G; D'Souza AM; Osaigbovo G; Berhe B; Osemwegie N; Reed X; Oshinaike O; Leonard H; Otubogun F; Alvarado CX; Oyakhire S; Ozomma S; Samuel S; Taiwo F; Wahab K; Zubair Y; Iwaki H; Kim JJ; Morris HR; Hardy J; Nalls M; Heilbron K; Norcliffe-Kaufmann L; ; Blauwendraat C; Houlden H; Singleton A; Okubadejo N
    medRxiv; 2023 May; ():. PubMed ID: 37398408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.
    Schumacher-Schuh AF; Bieger A; Okunoye O; Mok KY; Lim SY; Bardien S; Ahmad-Annuar A; Santos-Lobato BL; Strelow MZ; Salama M; Rao SC; Zewde YZ; Dindayal S; Azar J; Prashanth LK; Rajan R; Noyce AJ; Okubadejo N; Rizig M; Lesage S; Mata IF;
    Mov Disord; 2022 Aug; 37(8):1593-1604. PubMed ID: 35867623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's genetics research on underrepresented AfrAbia populations: current state and future prospects.
    Mohamed W
    Am J Neurodegener Dis; 2023; 12(2):23-41. PubMed ID: 37213711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging genetic diversity to understand monogenic Parkinson's disease's landscape in AfrAbia.
    Mohamed W
    Am J Neurodegener Dis; 2023; 12(4):108-122. PubMed ID: 37736165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic screening of Filipinos suspected with familial Parkinson's disease: A pilot study.
    Caritativo ECA; Yu JRT; Bautista JMP; Nishioka K; Jamora RDG; Yalung PM; Ng AR; Hattori N
    Parkinsonism Relat Disord; 2023 Mar; 108():105319. PubMed ID: 36774704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.
    Chase BA; Markopoulou K
    Front Neurol; 2020; 11():447. PubMed ID: 32547477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GP2: The Global Parkinson's Genetics Program.
    Global Parkinson's Genetics Program
    Mov Disord; 2021 Apr; 36(4):842-851. PubMed ID: 33513272
    [No Abstract]   [Full Text] [Related]  

  • 12. Author Correction: Elucidating causative gene variants in hereditary Parkinson's disease in the Global Parkinson's Genetics Program (GP2).
    Lange LM; Avenali M; Ellis M; Illarionova A; Keller Sarmiento IJ; Tan AH; Madoev H; Galandra C; Junker J; Roopnarain K; Solle J; Wegel C; Fang ZH; Heutink P; Kumar KR; Lim SY; Valente EM; Nalls M; Blauwendraat C; Singleton A; Mencacci N; Lohmann K; Klein C;
    NPJ Parkinsons Dis; 2023 Sep; 9(1):133. PubMed ID: 37704671
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
    Simuni T; Brumm MC; Uribe L; Caspell-Garcia C; Coffey CS; Siderowf A; Alcalay RN; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Nudelman K; Tosun-Turgut D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten S; Bressman S; Marek K;
    Mov Disord; 2020 May; 35(5):833-844. PubMed ID: 32073681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline genetic associations in the Parkinson's Progression Markers Initiative (PPMI).
    Nalls MA; Keller MF; Hernandez DG; Chen L; Stone DJ; Singleton AB;
    Mov Disord; 2016 Jan; 31(1):79-85. PubMed ID: 26268663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data.
    Fung HC; Scholz S; Matarin M; Simón-Sánchez J; Hernandez D; Britton A; Gibbs JR; Langefeld C; Stiegert ML; Schymick J; Okun MS; Mandel RJ; Fernandez HH; Foote KD; Rodríguez RL; Peckham E; De Vrieze FW; Gwinn-Hardy K; Hardy JA; Singleton A
    Lancet Neurol; 2006 Nov; 5(11):911-6. PubMed ID: 17052657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular genetics of Parkinson's disease].
    Shadrina MI; Slominskiĭ PA
    Genetika; 2006 Aug; 42(8):1045-59. PubMed ID: 17025154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease Research.
    Rajan R; Divya KP; Kandadai RM; Yadav R; Satagopam VP; Madhusoodanan UK; Agarwal P; Kumar N; Ferreira T; Kumar H; Sreeram Prasad AV; Shetty K; Mehta S; Desai S; Kumar S; Prashanth LK; Bhatt M; Wadia P; Ramalingam S; Wali GM; Pandey S; Bartusch F; Hannussek M; Krüger J; Kumar-Sreelatha A; Grover S; Lichtner P; Sturm M; Roeper J; Busskamp V; Chandak GR; Schwamborn J; Seth P; Gasser T; Riess O; Goyal V; Pal PK; Borgohain R; Krüger R; Kishore A; Sharma M;
    Front Neurol; 2020; 11():524. PubMed ID: 32655481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.
    Jia F; Fellner A; Kumar KR
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.